Rheumotologitsts’ view on the use of hydroxychloroquine to treat COVID-19

The current pandemic coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) calls urgently for effective therapies. Anti-malarial medicine chloroquine (CQ) and particularly its chemical analogue hydroxychloroquine (HCQ) have been recommended as...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Xiaoxuan, Ni, Yicheng, Zhang, Miaojia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241459/
https://www.ncbi.nlm.nih.gov/pubmed/32338155
http://dx.doi.org/10.1080/22221751.2020.1760145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241459/
https://www.ncbi.nlm.nih.gov/pubmed/32338155
http://dx.doi.org/10.1080/22221751.2020.1760145

Ejemplares similares